Spondylarthritis Clinical Trial
Official title:
Study of the Interest of Serum Calprotectin Determination in the Diagnosis of Spondyloarthritis and to Diferenciate With Fibromyalgia
To date, there are no biomarkers in spondyloarthritis that can differentiate between spondyloarthritis and fibromyalgia or other pathologies. Fecal calprotectin is a biomarker that is increasingly used in inflammatory diseases of the digestive tract. A growing interest in this biomarker is emerging in rheumatology, several publications have focused on its interest in rheumatoid arthritis, highlighting an association between serum calprotectin levels and disease activity. In spondyloarthritis, a few studies seem to show that it could be a marker of disease activity. Although a 2012 study found no difference in serum calprotectin levels between subjects with spondyloarthritis and controls. Still others have shown that it could be a predictive factor of radiological evolution in the same disease key. These data support, despite the questionable results of the Klingberg study, the value of this dosage in spondyloarthritis. The objective of this work is to show that this assay could be useful to differentiate spondyloarthritis from other pathologies with similar clinical presentation such as fibromyalgia. Difficulties classically encountered in common practice in rheumatology
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05494203 -
Multi-omics Study and Drug Intervention Study of Spondyloarthritis
|
||
| Completed |
NCT03818958 -
Seric Calprotectine in Spondyloarthritis
|
||
| Completed |
NCT01947465 -
Immunogenicity and Safety of Vaccinations in Immunocompromised Persons
|
N/A | |
| Recruiting |
NCT05926453 -
Assessment of Cardiorespiratory Fitness in Spondylarthritis
|
||
| Recruiting |
NCT05080218 -
COVID-19 VaccinE Response in Rheumatology Patients
|
Phase 4 | |
| Terminated |
NCT03454932 -
Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
|
||
| Completed |
NCT01314547 -
Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort
|
N/A | |
| Not yet recruiting |
NCT06273306 -
Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC)
|
N/A | |
| Recruiting |
NCT02809781 -
A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis
|
Phase 2/Phase 3 | |
| Completed |
NCT02098694 -
Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis
|
N/A | |
| Recruiting |
NCT00491933 -
Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
|
N/A | |
| Enrolling by invitation |
NCT04964661 -
Incidence of MRI Sacro-Iliac (SI) Joint Anomalies in Women With Spondyloarthritis (SpA)
|
||
| Completed |
NCT02473315 -
Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis
|
N/A | |
| Completed |
NCT03999489 -
Study of the Psychometric Properties and a Measure of Utility Determinants ( the SF- 6D) in Patients With Early Inflammatory Low Back Pain
|
||
| Recruiting |
NCT04519866 -
Clinical Trial of Electroacupuncture in Axial Spondyloarthritis (E-AcuSpA)
|
N/A | |
| Completed |
NCT02402894 -
Follow-up of Person-centered Care of Young Adults With Rheumatic Disease
|
||
| Recruiting |
NCT05592574 -
IL17 Rate and Spondyloarthritis
|
||
| Completed |
NCT02988674 -
A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation
|
||
| Recruiting |
NCT06460805 -
axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis
|
N/A | |
| Completed |
NCT01302730 -
Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study
|
N/A |